Drug Profile
Triptorelin - Immune System Regulation
Alternative Names: ISR-48; ISR048; Triptorelin acetate depot - Immune System RegulationLatest Information Update: 28 Mar 2023
Price :
$50
*
At a glance
- Originator Immune System Regulation
- Class Antineoplastics; Antivirals; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II HIV-1 infections
- No development reported Herpes simplex virus infections
Most Recent Events
- 28 Mar 2023 No recent reports of development identified for preclinical development in Herpes-simplex-virus-infections in Sweden
- 30 Mar 2021 Triptorelin is still in phase-II clinical trials in HIV-1 infections (Treatment-naive) in South Africa (IM) (Immune System Regulation pipeline, March 2021)
- 30 Mar 2021 Triptorelin is still in phase-II clinical trials in HIV-1 infections (Treatment-naive) in Sweden (IM) (Immune System Regulation pipeline, March 2021)